ALIMTA [pemetrexed] plus carboplatin as front-line chemotherapy for patients with locally advanced or metastatic non-small cell lung cancer: a phase 2 clinical trial
Latest Information Update: 21 Sep 2005
At a glance
- Drugs Carboplatin (Primary) ; Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 21 Sep 2005 New trial record.